A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
about
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.Association between Promoter Methylation of Gene ERCC3 and Benzene Hematotoxicity.Loss of MutL Disrupts Chk2-dependent Cell Cycle Control Through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.Nucleotide excision repair is a potential therapeutic target in multiple myeloma.Differential analysis of mutations in the Jewish population and their implications for diseases.Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
P2860
Q33677756-ADEE6215-AC2D-44B3-8088-7297C60A76C9Q38622341-B673D05B-EA44-4467-9BAB-A7A0A846C10FQ38628334-8A8C9863-E8F3-4FBF-A2C6-07D977F21E4EQ38739689-40C96516-B5E6-4A55-AFCB-CCA0D0E1CE25Q38787257-F5303D99-6291-4CF1-BE26-8C8F619820E6Q41470898-B5DD8023-FCB6-47F5-B9B3-56752F050B5AQ47801891-8631B6D8-FF23-477B-B643-3A1EA89F90CC
P2860
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
@en
type
label
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
@en
prefLabel
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
@en
P2093
P2860
P50
P1433
P1476
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
@en
P2093
Anne Lincoln
Brandon Wenz
Danylo Villano
Flavio Lejbkowicz
Hedy Rennert
Kara N Maxwell
Liying Zhang
Michael F Walsh
Pragna Gaddam
P2860
P304
P356
10.1158/2159-8290.CD-16-0487
P50
P577
2016-09-21T00:00:00Z